Keyword - Time Factors

Consultations about randomised controlled trials are shorter and less in-depth for socioeconomically disadvantaged patients compared to socioeconomically advantaged patients: qualitative analysis across three trials.
Popa, Mariana; Young, Bridget; Rousseau, Nikki; Cherry, Mary G; Jenkins, Isobel; Cloke, Jane; Pettitt, Andrew; Jenkinson, Michael D; Ahmed, Saiqa; Pemberton, Allan R; Sherratt, Frances C
Trials, Volume 25, Issue 1 (2024)
PMID: 38872208 DOI: 10.1186/s13063-024-08216-4 
Citations: -
Tags: HACAL

Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure.
Leone, Maurizio A; Giussani, Giorgia; Nevitt, Sarah J; Marson, Anthony G; Beghi, Ettore
Cochrane Database Syst Rev, Volume 5, Issue 5 (2021)
PMID: 33942281 DOI: 10.1002/14651858.CD007144.pub3 
Citations: 10 (Scopus)
Tags: PCCC

Repositioning for pressure injury prevention in adults.
Gillespie, Brigid M; Walker, Rachel M; Latimer, Sharon L; Thalib, Lukman; Whitty, Jennifer A; McInnes, Elizabeth; Chaboyer, Wendy P
Cochrane Database Syst Rev, Volume 6, Issue 6 (2020)
PMID: 32484259 DOI: 10.1002/14651858.CD009958.pub3 
Citations: 47 (Scopus)
Tags: MIDAS

Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study.
Banerjee, Amitava; Benedetto, Valerio; Gichuru, Philip; Burnell, Jane; Antoniou, Sotiris; Schilling, Richard J; Strain, William David; Ryan, Ronan; Watkins, Caroline; Marshall, Tom; Sutton, Chris J
Heart, Volume 106, Issue 2 (2020)
PMID: 31601729 DOI: 10.1136/heartjnl-2019-315307 
Citations: 80 (Scopus)
Tags: MIDAS

Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Nevitt, Sarah J; Marson, Anthony G; Tudur Smith, Catrin
Cochrane Database Syst Rev, Volume 10, Issue 10 (2018)
PMID: 30353945 DOI: 10.1002/14651858.CD001904.pub4 
Citations: 8 (Scopus)
Tags: CLAHRC

Renal function monitoring in heart failure - what is the optimal frequency? A narrative review.
Al-Naher, Ahmed; Wright, David; Devonald, Mark Alexander John; Pirmohamed, Munir
Br J Clin Pharmacol, Volume 84, Issue 1 (2018)
PMID: 28901643 DOI: 10.1111/bcp.13434 
Citations: 26 (Scopus)
Tags: CLAHRC

Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine.
Eleuteri, Antonio; Fisher, Anthony C; Broadbent, Deborah M; García-Fiñana, Marta; Cheyne, Christopher P; Wang, Amu; Stratton, Irene M; Gabbay, Mark; Seddon, Daniel; Harding, Simon P
Diabetologia, Volume 60, Issue 11 (2017)
PMID: 28840258 DOI: 10.1007/s00125-017-4386-0 
Citations: 30 (Scopus)
Tags: CLAHRC

Risk of a seizure recurrence after a breakthrough seizure and the implications for driving: further analysis of the standard versus new antiepileptic drugs (SANAD) randomised controlled trial.
Bonnett, L J; Powell, G A; Tudur Smith, C; Marson, A G
BMJ Open, Volume 7, Issue 7 (2017)
PMID: 28698335 DOI: 10.1136/bmjopen-2017-015868 
Citations: 12 (Scopus)
Tags: CLAHRC

Recurrence of sickness absence episodes certified by general practitioners in the UK.
Shiels, Chris; Gabbay, Mark; Hillage, Jim
Eur J Gen Pract, Volume 22, Issue 2 (2016)
PMID: 27102090 DOI: 10.3109/13814788.2016.1156083 
Citations: 3 (Scopus)
Tags: CLAHRC

Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure.
Leone, Maurizio A; Giussani, Giorgia; Nolan, Sarah J; Marson, Anthony G; Beghi, Ettore
Cochrane Database Syst Rev, Volume 2016, Issue 5 (2016)
PMID: 27150433 DOI: 10.1002/14651858.CD007144.pub2 
Citations: 35 (Scopus)
Tags: CLAHRC